We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
(+11%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 5 |
Steel Dynamics
STLD
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$176M |
| 2 |
Coca-Cola
KO
|
+$151M |
| 3 |
Broadcom
AVGO
|
+$146M |
| 4 |
Microsoft
MSFT
|
+$140M |
| 5 |
ExxonMobil
XOM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Industrials | 11.65% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.56% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
ExxonMobil
XOM
$651B
| $24.1M | 0.13% |
218,552
-1,282,747
| -85% | -$137M |
|
|
WWE
227
DELISTED
World Wrestling Entertainment
WWE
| $24M | 0.13% |
350,913
+331,069
| +1,668% | +$25M |
|
228
Roku
ROKU
$21.1B
| $24M | 0.13% |
589,492
+536,780
| +1,018% | +$28M |
|
229
Pinnacle West Capital
PNW
$12.9B
| $23.9M | 0.13% |
314,715
+202,176
| +180% | +$14.4M |
|
230
Manhattan Associates
MANH
$8.97B
| $23.9M | 0.13% |
197,081
+88,819
| +82% | +$10.9M |
|
231
Hilton Worldwide
HLT
$74B
| $23.8M | 0.13% |
+188,619
| New | +$24.9M |
|
232
Trade Desk
TTD
$8.13B
| $23.8M | 0.13% |
531,102
+446,803
| +530% | +$22.7M |
|
|
LSI
233
DELISTED
Life Storage, Inc.
LSI
| $23.8M | 0.13% |
+241,123
| New | +$25.3M |
|
|
DQ
234
Daqo New Energy
DQ
$790M
| $23.7M | 0.13% |
613,379
+257,553
| +72% | +$12.6M |
|
235
PUT
ConocoPhillips
COP
$147B
| $23.6M | 0.13% |
200,000
| – | – |
|
236
Canadian National Railway
CNI
$78.3B
| $23.5M | 0.13% |
197,850
+12,513
| +7% | +$1.5M |
|
237
PUT
Mastercard
MA
$477B
| $23.5M | 0.13% |
67,500
+40,000
| +145% | +$13.2M |
|
238
BorgWarner
BWA
$13.2B
| $23.5M | 0.13% |
662,432
+104,932
| +19% | +$3.57M |
|
239
Fox Class B
FOX
$20.7B
| $23.4M | 0.13% |
823,350
+606,440
| +280% | +$17.4M |
|
240
Shell
SHEL
$245B
| $23.4M | 0.13% |
+411,048
| New | +$22.7M |
|
241
Bank of America
BAC
$435B
| $23.2M | 0.12% |
701,485
-1,719,453
| -71% | -$59.2M |
|
242
Corpay
CPAY
$24.2B
| $23.1M | 0.12% |
125,675
-83,254
| -40% | -$15.3M |
|
243
Vodafone
VOD
$34.9B
| $22.9M | 0.12% |
2,262,350
+2,054,275
| +987% | +$23.1M |
|
244
Principal Financial Group
PFG
$23.6B
| $22.9M | 0.12% |
+272,774
| New | +$23.4M |
|
245
TransUnion
TRU
$14.8B
| $22.7M | 0.12% |
400,787
+170,835
| +74% | +$10M |
|
246
Comcast
CMCSA
$79.1B
| $22.7M | 0.12% |
648,605
-2,628,896
| -80% | -$87M |
|
247
Elanco Animal Health
ELAN
$12.4B
| $22.6M | 0.12% |
1,850,422
+1,016,981
| +122% | +$12.7M |
|
248
Huntington Ingalls Industries
HII
$11.3B
| $22.5M | 0.12% |
97,474
+20,225
| +26% | +$4.76M |
|
249
Edwards Lifesciences
EW
$47.6B
| $22.3M | 0.12% |
299,276
-24,782
| -8% | -$1.91M |
|
250
Airbnb
ABNB
$83.7B
| $22.3M | 0.12% |
261,046
+13,361
| +5% | +$1.35M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review
As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
- Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
- Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
- Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.